FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:450-458 February 3, 2005 Number 5 Next

	Return to Search Result Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Vázquez, M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Varicella disease has been preventable in the United States since 1995. Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella.

Methods Data on deaths for which varicella was listed as an underlying or contributing cause were obtained from National Center for Health Statistics Multiple Cause-of-Death Mortality Data for 1990 through 2001. We calculated the numbers and rates of death due to varicella according to age, sex, race, ethnic background, and birthplace.

Results The rate of death due to varicella fluctuated from 1990 through 1998 and then declined sharply. For the interval from 1990 through 1994, the average number of varicella-related deaths was 145 per year (varicella was listed as the underlying cause in 105 deaths and as a contributing cause in 40); it then declined to 66 per year during 1999 through 2001. For deaths for which varicella was listed as the underlying cause, age-adjusted mortality rates dropped by 66 percent, from an average of 0.41 death per 1 million population during 1990 through 1994 to 0.14 during 1999 through 2001 (P<0.001). This decline was observed in all age groups under 50 years, with the greatest reduction (92 percent) among children 1 to 4 years of age. In addition, by the period from 1999 through 2001, the average rates of mortality due to varicella among all racial and ethnic groups were below 0.15 per 1 million population, as compared with rates ranging from 0.37 per 1 million for whites to 0.66 per 1 million for other races in the period from 1990 through 1994.

Conclusions The program of universal childhood vaccination against varicella in the United States has resulted in a sharp decline in the rate of death due to varicella.

Source Information

From the National Immunization Program, Centers for Disease Control and Prevention, Atlanta.

Address reprint requests to Dr. Seward at the Viral Vaccine Preventable Disease Branch, National Immunization Program, CDC, 1600 Clifton Rd., Mailstop E-61, Atlanta, GA 30333, or at jseward{at}cdc.gov.

Full Text of this Article

Related Letters:

Decline in Mortality with Varicella Vaccination
Giacchino R., Losurdo G., Castagnola E.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:1819, Apr 28, 2005. Correspondence

This article has been cited by other articles:

• Holmes, M. V., Atabani, S. F, Khan, N., Steiner, K., Haque, T., Slapak, G. (2009). A case for varicella vaccination in the immunosuppressed. BMJ Case Reports 2009: bcr0720080461-bcr0720080461 [Abstract] [Full Text]  
• Quian, J, Ruttimann, R, Romero, C, Dall'Orso, P, Cerisola, A, Breuer, T, Greenberg, M, Verstraeten, T (2008). Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch. Dis. Child. 93: 845-850 [Abstract] [Full Text]  
• Marin, M., Meissner, H. C., Seward, J. F. (2008). Varicella Prevention in the United States: A Review of Successes and Challenges. Pediatrics 122: e744-e751 [Abstract] [Full Text]  
• Farlow, A. (2008). Childhood immunisation against varicella zoster virus. BMJ 337: a1164-a1164 [Full Text]  
• Fishbein, D. B., Broder, K. R., Markowitz, L., Messonnier, N. (2008). New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent. Pediatrics 121: S5-S14 [Abstract] [Full Text]  
• Roush, S. W., Murphy, T. V., and the Vaccine-Preventable Disease Table Working, (2007). Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States. JAMA 298: 2155-2163 [Abstract] [Full Text]  
• Jean-Philippe, P., Freedman, A., Chang, M. W., Steinberg, S. P., Gershon, A. A., LaRussa, P. S., Borkowsky, W. (2007). Severe Varicella Caused by Varicella-Vaccine Strain in a Child With Significant T-Cell Dysfunction. Pediatrics 120: e1345-e1349 [Abstract] [Full Text]  
• Committee on Infectious Diseases, (2007). Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule. Pediatrics 120: 221-231 [Abstract] [Full Text]  
• Gershon, A. A., Arvin, A. M., Shapiro, E., Senanayake, S. N., Chaves, S. S., Seward, J. F. (2007). Varicella Vaccine. NEJM 356: 2648-2649 [Full Text]  
• Chaves, S. S., Gargiullo, P., Zhang, J. X., Civen, R., Guris, D., Mascola, L., Seward, J. F. (2007). Loss of Vaccine-Induced Immunity to Varicella over Time. NEJM 356: 1121-1129 [Abstract] [Full Text]  
• Davis, M. M., Marin, M., Cowan, A. E., Guris, D., Clark, S. J. (2007). Physician Attitudes Regarding Breakthrough Varicella Disease and a Potential Second Dose of Varicella Vaccine. Pediatrics 119: 258-264 [Abstract] [Full Text]  
• Nysse, L. J., Pinsky, N. A., Bratberg, J. P., Babar-Weber, A. Y., Samuel, T. T., Krych, E. H., Ziegler, A. W., Jimale, M. A., Vierkant, R. A., Jacobson, R. M., Poland, G. A. (2007). Seroprevalence of Antibody to Varicella Among Somali Refugees. Mayo Clin Proc. 82: 175-180 [Abstract] [Full Text]  
• Wood, M., Wyllie, R., Foster, H. (2006). A balancing act. EDUCATION AND PRACTICE 91: ep68-ep74 [Full Text]  
• Goldman, G. S. (2006). The Case against Universal Varicella Vaccination. International Journal of Toxicology 25: 313-317 [Abstract] [Full Text]  
• Mmeje, O., Davis, M. M. (2006). Will Coverage for Child and Adolescent Immunizations Be Mandated for Insurance Plans in 2006? Lessons Learned From the Newborns' and Mothers' Health Protection Act of 1996. Pediatrics 118: 388-392 [Full Text]  
• Lopez, A. S., Guris, D., Zimmerman, L., Gladden, L., Moore, T., Haselow, D. T., Loparev, V. N., Schmid, D. S., Jumaan, A. O., Snow, S. L. (2006). One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117: e1070-e1077 [Abstract] [Full Text]  
• Staat, M. A., Meinzen-Derr, J., Welch, T., Roberts, N. E., Jamison, L., Gerber, M. A., Morrow, A. L. (2006). Varicella-Related Hospitalization and Emergency Department Visit Rates, Before and After Introduction of Varicella Vaccine, Among White and Black Children in Hamilton County, Ohio. Pediatrics 117: e833-e839 [Abstract] [Full Text]  
• Grace, J. A. (2006). Adolescent Immunization: Challenges and Opportunities. The Journal of School Nursing 22: 87-93 [Abstract] [Full Text]  
• Luman, E. T., Ching, P. L. Y. H., Jumaan, A. O., Seward, J. F. (2006). Uptake of Varicella Vaccination Among Young Children in the United States: A Success Story in Eliminating Racial and Ethnic Disparities. Pediatrics 117: 999-1008 [Abstract] [Full Text]  
• Reisinger, K. S., Hoffman Brown, M. L., Xu, J., Sullivan, B. J., Marshall, G. S., Nauert, B., Matson, D. O., Silas, P. E., Protocol 014 Study Group for ProQuad, , Schodel, F., Gress, J. O., Kuter, B. J. (2006). A Combination Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) Given to 4- to 6-Year-Old Healthy Children Vaccinated Previously With M-M-RII and Varivax. Pediatrics 117: 265-272 [Abstract] [Full Text]  
• Bhat, N., Wright, J. G., Broder, K. R., Murray, E. L., Greenberg, M. E., Glover, M. J., Likos, A. M., Posey, D. L., Klimov, A., Lindstrom, S. E., Balish, A., Medina, M.-j., Wallis, T. R., Guarner, J., Paddock, C. D., Shieh, W.-J., Zaki, S. R., Sejvar, J. J., Shay, D. K., Harper, S. A., Cox, N. J., Fukuda, K., Uyeki, T. M., the Influenza Special Investigations Team, (2005). Influenza-Associated Deaths among Children in the United States, 2003-2004. NEJM 353: 2559-2567 [Abstract] [Full Text]  
• Zhou, F., Santoli, J., Messonnier, M. L., Yusuf, H. R., Shefer, A., Chu, S. Y., Rodewald, L., Harpaz, R. (2005). Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001. Arch Pediatr Adolesc Med 159: 1136-1144 [Abstract] [Full Text]  
• Zhou, F., Harpaz, R., Jumaan, A. O., Winston, C. A., Shefer, A. (2005). Impact of Varicella Vaccination on Health Care Utilization. JAMA 294: 797-802 [Abstract] [Full Text]  
• Davis, M. M. (2005). Varicella Vaccine, Cost-effectiveness Analyses, and Vaccination Policy. JAMA 294: 845-846 [Full Text]  
• (2005). Journal Watch. Arch. Dis. Child. 90: 651-652 [Full Text]  
• Orenstein, W. A., Douglas, R. G., Rodewald, L. E., Hinman, A. R. (2005). Immunizations In The United States: Success, Structure, And Stress. Health Aff (Millwood) 24: 599-610 [Abstract] [Full Text]  
• Giacchino, R., Losurdo, G., Castagnola, E. (2005). Decline in Mortality with Varicella Vaccination. NEJM 352: 1819-1819 [Full Text]  
• (2005). Varicella Deaths Decline Sharply After Universal Vaccination Adopted. JWatch Infect. Diseases 2005: 5-5 [Full Text]  
• (2005). The Impact of Varicella Vaccine. JWatch Pediatrics 2005: 1-1 [Full Text]  
• (2005). Varicella Vaccine Leads to Decline in Mortality. JWatch General 2005: 3-3 [Full Text]